| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |